Antoine Kimmoun Selected Research

Hypotension (Low Blood Pressure)

1/2021	Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.
11/2019	Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study.
1/2016	If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock.
9/2015	β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
12/2014	Angiotensin II: a new approach for refractory shock management?
3/2013	Mechanisms of vascular hyporesponsiveness in septic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antoine Kimmoun Research Topics

Disease

23	Cardiogenic Shock 05/2024 - 01/2014
17	Heart Failure 05/2024 - 01/2017
12	Shock 02/2022 - 03/2013
10	Septic Shock (Toxic Shock Syndrome) 07/2022 - 05/2012
9	COVID-19 01/2023 - 01/2020
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2024 - 12/2015
8	Critical Illness (Critically Ill) 01/2023 - 03/2013
8	Sepsis (Septicemia) 02/2022 - 12/2011
7	Heart Arrest (Cardiac Arrest) 05/2024 - 12/2016
6	Myocardial Infarction 06/2022 - 04/2014
6	Hypotension (Low Blood Pressure) 01/2021 - 03/2013
5	Inflammation (Inflammations) 06/2022 - 02/2018
4	Hypothermia 03/2024 - 01/2017
4	Hemorrhage 02/2022 - 07/2020
4	Lactic Acidosis 10/2018 - 07/2013
3	Hyperlactatemia 03/2024 - 04/2014
3	Ischemia 03/2024 - 01/2017
3	Wounds and Injuries (Trauma) 06/2022 - 07/2020
3	Stroke (Strokes) 02/2022 - 05/2012
2	Human Influenza (Influenza) 01/2023 - 01/2019
2	Infections 10/2022 - 06/2021
2	Ventricular Fibrillation 01/2022 - 01/2017
2	Anemia 10/2020 - 07/2020
2	Thrombocytopenia (Thrombopenia) 01/2020 - 09/2018
2	Thyroid Crisis (Thyrotoxic Crisis) 01/2020 - 10/2011
2	Vasoplegia 02/2018 - 03/2013
2	Out-of-Hospital Cardiac Arrest 01/2018 - 01/2016
2	Peritonitis 01/2016 - 09/2015
2	Hypocalcemia 04/2015 - 04/2014
2	Acidosis 04/2014 - 09/2012
2	Cardiac Arrhythmias (Arrythmia) 07/2013 - 05/2012
1	Pressure Ulcer (Bedsore) 12/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2023
1	Thrombosis (Thrombus) 01/2023
1	Amniotic Fluid Embolism 01/2022
1	Hyperoxia 01/2022
1	Catheter-Related Infections 06/2021
1	Acute Kidney Injury (Acute Renal Failure) 12/2020
1	Liver Diseases (Liver Disease) 12/2020
1	Anaphylaxis (Anaphylactic Shock) 12/2020
1	Pulmonary Edema 01/2020

Drug/Important Bio-Agent (IBA)

11	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 05/2012
7	Epinephrine (Adrenaline)FDA LinkGeneric 12/2020 - 05/2012
6	esmolol (Brevibloc)FDA LinkGeneric 07/2022 - 09/2015
5	CatecholaminesIBA 01/2020 - 03/2013
4	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 11/2019
4	Erythropoietin FDA Link 10/2020 - 01/2016
4	Vasoconstrictor AgentsIBA 10/2018 - 03/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 03/2024 - 01/2017
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 05/2012
3	Vasopressins (Vasopressin)IBA 01/2020 - 03/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018 - 03/2013
3	salicylhydroxamic acid (SHAM)IBA 01/2016 - 04/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2020
2	IronIBA 10/2020 - 07/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 09/2018
2	Growth Differentiation Factor 15IBA 11/2019 - 11/2019
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2018 - 03/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2018 - 12/2015
2	Colloids (Colloid)IBA 10/2017 - 11/2013
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2013
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 04/2015 - 04/2014
2	Bicarbonates (Hydrogen Carbonate)IBA 04/2015 - 04/2014
2	Carbon DioxideIBA 04/2015 - 04/2014
2	Angiotensin IIIBA 12/2014 - 11/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2023
1	antineoplaston A10 (A 10)IBA 01/2023
1	landiololIBA 07/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2022
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 06/2022
1	tocilizumab (atlizumab)FDA Link 04/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	Lopinavir FDA Link 12/2021
1	Ritonavir (Norvir)FDA Link 12/2021
1	AdrenomedullinIBA 09/2021
1	A-factor (Streptomyces)IBA 06/2021
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020
1	NitrogenIBA 10/2020
1	Urea (Carbamide)FDA LinkGeneric 10/2020
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2020

Therapy/Procedure

27	Therapeutics 05/2024 - 09/2012
18	Extracorporeal Membrane Oxygenation 05/2024 - 01/2017
9	Critical Care (Surgical Intensive Care) 10/2022 - 03/2008
9	Resuscitation 01/2022 - 11/2013
6	Artificial Respiration (Mechanical Ventilation) 12/2023 - 07/2017
5	Ligation 01/2022 - 09/2015
4	Length of Stay 12/2023 - 07/2020
4	Catheters 01/2023 - 05/2012
3	Cardiopulmonary Resuscitation (CPR) 01/2022 - 01/2017
2	Patient Readmission 03/2024 - 11/2023
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023 - 02/2022
2	Punctures 01/2022 - 09/2015
2	Contraindications 10/2020 - 07/2020
2	Erythrocyte Transfusion 10/2020 - 07/2020
1	Immunomodulation 01/2023
1	Mechanical Ventilators (Ventilator) 02/2022
1	Heart-Assist Devices 02/2022